Navigation Links
Burroughs Wellcome Fund grants $9.75 million towards translational researchers
Date:3/7/2008

RESEARCH TRIANGLE PARK, N.C. BWF has named 13 translational researchers as the 2008 recipients of its Clinical Scientist Awards in Translational Research. The awards, which provide $150,000 per year over five years ($750,000), are intended to support established, independent physician-scientists who are dedicated to translational researchthe two-way transfer between laboratory research and patient treatmentand mentoring physician-scientist trainees.

The award provides the freedom and flexibility to explore scientific questions, apply the resulting knowledge at the bedside, and bring insights from the clinical setting back to the laboratory for further study.

The Clinical Scientist Awards in Translational Research is in its tenth cycle. The award is highly competitive with an average award rate of 9 percent. In the 2008 cycle, there were 119 eligible applications. Candidates must have an M.D. or M.D.-Ph.D. degree and hold an appointment or joint appointment in a subspecialty of clinical medicine. They must also be citizens or permanent residents of the U.S. and Canada and hold a current license to practice medicine in the U.S. or Canada.

We hope these awards will lead to better understanding of the mechanisms of disease as well as new methods of diagnosing, treating and preventing disease, said BWF President Enriqueta C. Bond, Ph.D. BWF is particularly interested in supporting physician-scientists who bring novel ideas and new approaches to translational research.

Since the awards inception in 1997, BWF has made a total of 93 awardsan investment of nearly $70 million in the careers of translational researchers.

Following are the 2008 award recipients, along with their institutions and project titles:

Mark S. Anderson, M.D., Ph.D.
University of California-San Francisco
Translating aire-control of immune tolerance to human autoimmunity

Kathleen L. Collins, M.D., Ph.D.
University of Michigan-Ann Arbor
Viral mechanisms of persistence in HIV infected people

Laurence Cooper, M.D., Ph.D.
University of Texas M.D. Anderson Cancer Center
Tumor-specific alloantigen-anergic donor-derived T-cell therapy after hematopoietic stem cell transplantation

William M. Grady, M.D.
University of Washington
Novel biomarkers for the prevention and treatment of colon cancer

S. Ananth Karumanchi, M.D.
Harvard Medical School
Soluble endoglin in the pathogenesis and prediction of preclampsia

Frances Lee, M.D., Ph.D.
Weill Medical College of Cornell University
Role of BDNF in therapeutic strategies for affective disorders

Ernst R. Lengyel, M.D., Ph.D.
University of Chicago
Development of novel therapeutic and diagnostic strategies for ovarian cancer

Daniel L. Marks, M.D., Ph.D.
Oregon Health and Science University
Maternal nutrition and fetal metabolic programming

Jonathan R. Pollack, M.D., Ph.D.
Stanford University
Pathogenesis and diagnosis of clinically-indolent prostate cancer

Theodora S. Ross, M.D., Ph.D.
University of Michigan-Ann Arbor
Abnormal HIP1 and cancer biology

Jeffrey A. Toretsky, M.D.
Georgetown University Lombardi Comprehensive Cancer Center
Novel cancer therapeutics based upon oncogenic fusion-protein transcription factors

Edus H. Warren, M.D., Ph.D.
University of Washington
Toward immune therapy for colon cancer: identification of antigens recognized by CD8+ T lymphocytes on colon cancer stem cells

Kang Zhang, M.D., Ph.D.
University of Utah
Define novel genes for diabetic microvascular complications


'/>"/>

Contact: Russ Campbell
news@bwfund.org
919-991-5119
Burroughs Wellcome Fund
Source:Eurekalert

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... York, NY (PRWEB) , ... February 10, 2016 , ... ... campaign to celebrate and raise awareness of Nestlé KITKAT as the first global confectionery ... the lives of cocoa farmers and the quality of their product, through activities that ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... to expand dental health services to the developmentally disabled in the Coachella Valley. ... operations to a new facility at 71-949 Highway 111, Suite 100-B, in Rancho ...
(Date:2/10/2016)... Washington (PRWEB) , ... February 10, 2016 , ... ... access and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart ... remote interpreting (VRI). , For nearly 23 years, Heart City Health Center has ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... a master charity program created to assist the local community. Pledging to select ... leaders and nonprofit organizations in the area. Their goal is to bring community ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... ... Valley , announces that his office is now offering a variety of comprehensive ... enhancement, chin enhancement, eyebrow lift, facial volume restoration, lip enhancement and nasal reshaping. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SEATTLE , Feb. 10, 2016  Resolve ... potentially transformative new approaches to the treatment of ... completion of a multiple ascending dose study in ... lead compound RSLV-132. --> ... double-blind, placebo-controlled multiple ascending dose study of RSLV-132 ...
(Date:2/10/2016)...  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" ... of its issued and outstanding shares of common stock ... 11, 2016. The Company,s common stock will trade on ... temporary ticker symbol "RCHAD". After 20 trading days, the ... (RCHA).  --> --> ...
(Date:2/10/2016)... Tenn. , Feb. 10, 2016 /PRNewswire/ ... of Nursing received an in-kind gift ... of a VeinViewer® Vision vein finder for ... will help students as they learn how ... combining technology with traditional technique. ...
Breaking Medicine Technology: